Dr. Peter Farrell to remain Chairman of the Board
SAN DIEGO, Aug. 30 /PRNewswire-FirstCall/ -- ResMed Inc. (NYSE: RMD) announced today that its board of directors has unanimously approved a succession plan for executive management of the company. Effective January 1, 2008, Kieran T. Gallahue will be promoted to Chief Executive Officer and will join the board of directors. Mr. Gallahue, 44, will succeed Dr. Peter C. Farrell, 65. As of January 1, 2008, Dr. Farrell will relinquish his position as CEO, but will continue serving as Executive Chairman of the Board until June 30, 2008, when he will become non-executive Chairman.
"Since joining ResMed in 2003, Kieran has demonstrated strong leadership qualities," said Dr. Farrell. "He has been instrumental in improving our operational execution, targeting our research and development efforts, focusing our commercial teams to better serve patients and customers, while strengthening the depth of our management. He has earned the respect of our employees and customers. He has the full support of myself and the Board, and is the right person to succeed me as ResMed's Chief Executive Officer."
"Since founding the company in 1989, I have been passionate about the
need to increase awareness of sleep-disordered breathing among both the
public and the medical community, as well as the need to increase
understanding of the deleterious consequences of the dise
|SOURCE ResMed Inc.|
Copyright©2007 PR Newswire.
All rights reserved